Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432510 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00432510 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 27 participants.
The verdict
NCT00432510, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The study objective was to describe the pharmacokinetics (PK) of one or two doses of C1 esterase inhibitor (C1INH-nf) in hereditary angioedema (HAE) subjects who were not experiencing an HAE attack.
Interventions
- DRUG C1 esterase inhibitor [human] (C1INH-nf)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2006-10-09 |
| Est. Completion | 2007-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00432510
The ClinicalTrials.gov registry entry for NCT00432510 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which C1 esterase inhibitor [human] (C1INH-nf) is the first listed.
NCT00432510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00432510 about?
NCT00432510 is a clinical study titled "Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects". The study objective was to describe the pharmacokinetics (PK) of one or two doses of C1 esterase inhibitor (C1INH-nf) in hereditary angioedema (HAE) subjects who were not experiencing an HAE attack.
What is the current status of trial NCT00432510?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2006-10-09. Estimated completion is 2007-02-28.
What interventions are being tested in trial NCT00432510?
The interventions under investigation include: C1 esterase inhibitor [human] (C1INH-nf) (DRUG).
Who is sponsoring clinical trial NCT00432510?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.